119 related articles for article (PubMed ID: 9419825)
1. Detection of myocardial viability with F-18-fluorodeoxyglucose and single photon emission computed tomography.
Bax JJ; Valkema R; Visser FC; Poldermans D; Cornel JH; van Lingen A; Krenning EP; Rambaldi R; Roelandt JR; Visser CA; Fioretti PM
G Ital Cardiol; 1997 Nov; 27(11):1181-6. PubMed ID: 9419825
[TBL] [Abstract][Full Text] [Related]
2. FDG SPECT in the assessment of myocardial viability. Comparison with dobutamine echo.
Bax JJ; Valkema R; Visser FC; van Lingen A; Cornel JH; Poldermans D; Rambaldi R; Krenning EP; Fioretti PM
Eur Heart J; 1997 Jun; 18 Suppl D():D124-9. PubMed ID: 9183621
[TBL] [Abstract][Full Text] [Related]
3. Prediction of improvement of ventricular function after revascularization. 18F-fluorodeoxyglucose single-photon emission computed tomography vs low-dose dobutamine echocardiography.
Cornel JH; Bax JJ; Fioretti PM; Visser FC; Maat AP; Boersma E; van Lingen A; Elhendy A; Roelandt JR
Eur Heart J; 1997 Jun; 18(6):941-8. PubMed ID: 9183585
[TBL] [Abstract][Full Text] [Related]
4. Head-to-head comparison of exercise-redistribution-reinjection thallium single-photon emission computed tomography and low dose dobutamine echocardiography for prediction of reversibility of chronic left ventricular ischemic dysfunction.
Vanoverschelde JL; D'Hondt AM; Marwick T; Gerber BL; De Kock M; Dion R; Wijns W; Melin JA
J Am Coll Cardiol; 1996 Aug; 28(2):432-42. PubMed ID: 8800122
[TBL] [Abstract][Full Text] [Related]
5. Prediction of recovery of myocardial dysfunction after revascularization. Comparison of fluorine-18 fluorodeoxyglucose/thallium-201 SPECT, thallium-201 stress-reinjection SPECT and dobutamine echocardiography.
Bax JJ; Cornel JH; Visser FC; Fioretti PM; van Lingen A; Reijs AE; Boersma E; Teule GJ; Visser CA
J Am Coll Cardiol; 1996 Sep; 28(3):558-64. PubMed ID: 8772739
[TBL] [Abstract][Full Text] [Related]
6. Preoperative comparison of different noninvasive strategies for predicting improvement in left ventricular function after coronary artery bypass grafting.
Bax JJ; Maddahi J; Poldermans D; Elhendy A; Schinkel A; Boersma E; Valkema R; Krenning EP; Roelandt JR; van der Wall EE
Am J Cardiol; 2003 Jul; 92(1):1-4. PubMed ID: 12842235
[TBL] [Abstract][Full Text] [Related]
7. Myocardial viability by contrast-enhanced cardiovascular magnetic resonance in patients with coronary artery disease: comparison with gated single-photon emission tomography and FDG position emission tomography.
Wu YW; Tadamura E; Kanao S; Yamamuro M; Marui A; Komeda M; Toma M; Kimura T; Togashi K
Int J Cardiovasc Imaging; 2007 Dec; 23(6):757-65. PubMed ID: 17364219
[TBL] [Abstract][Full Text] [Related]
8. 18-Fluorodeoxyglucose imaging with positron emission tomography and single photon emission computed tomography: cardiac applications.
Bax JJ; Patton JA; Poldermans D; Elhendy A; Sandler MP
Semin Nucl Med; 2000 Oct; 30(4):281-98. PubMed ID: 11105929
[TBL] [Abstract][Full Text] [Related]
9. Comparison of fluorine-18-FDG with rest-redistribution thallium-201 SPECT to delineate viable myocardium and predict functional recovery after revascularization.
Bax JJ; Cornel JH; Visser FC; Fioretti PM; van Lingen A; Huitink JM; Elhendy A; Poldermans D; Roelandt JR; Visser CA
J Nucl Med; 1998 Sep; 39(9):1481-6. PubMed ID: 9744328
[No Abstract] [Full Text] [Related]
10. Identification of hibernating myocardium: a comparison between dobutamine echocardiography and study of perfusion and metabolism in patients with severe left ventricular dysfunction.
Mariani MA; Palagi C; Donatelli F; Mengozzi G; Biadi O; Vanoli G; Landoni C; Paolini G; Lucignani G; Fazio F
Am J Card Imaging; 1995 Jan; 9(1):1-8. PubMed ID: 7894227
[TBL] [Abstract][Full Text] [Related]
11. Agreement and disagreement between "metabolic viability" and "contractile reserve" in akinetic myocardium.
Cornel JH; Bax JJ; Elhendy A; Visser FC; Boersma E; Poldermans D; Sloof GW; Fioretti PM
J Nucl Cardiol; 1999; 6(4):383-8. PubMed ID: 10461604
[TBL] [Abstract][Full Text] [Related]
12. [18F]fluorodeoxyglucose single photon emission computed tomography: can it replace PET and thallium SPECT for the assessment of myocardial viability?
Srinivasan G; Kitsiou AN; Bacharach SL; Bartlett ML; Miller-Davis C; Dilsizian V
Circulation; 1998 Mar; 97(9):843-50. PubMed ID: 9521332
[TBL] [Abstract][Full Text] [Related]
13. Improved identification of viable myocardium using second harmonic imaging during dobutamine stress echocardiography.
Sozzi FB; Poldermans D; Bax JJ; Elhendy A; Vourvouri EC; Valkema R; De Sutter J; Schinkel AF; Borghetti A; Roelandt JR
Heart; 2001 Dec; 86(6):672-8. PubMed ID: 11711466
[TBL] [Abstract][Full Text] [Related]
14. Myocardial viability assessment after acute myocardial infarction: low-dose dobutamine echocardiography versus rest-redistribution thallium-201 SPECT.
Castini D; Bestetti A; Garbin M; Di Leo C; Bigi R; Sponzilli C; Concardi G; Gioventù M; Tarolo GL; Lombardi F; Fiorentini C
Cardiologia; 1999 Sep; 44(9):817-23. PubMed ID: 10609391
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the clinical value of combination of 99mTc-MIBI myocardial SPECT and 18F-FDG PET in assessing myocardial viability.
Zhang X; Liu X; Shi R; Wu Q; Gao R; Liu Y; Hu S; Guo S; Xie F; Li Y
Radiat Med; 1999; 17(3):205-10. PubMed ID: 10440109
[TBL] [Abstract][Full Text] [Related]
16. Role of F-18 FDG positron emission tomography (PET) in the assessment of myocardial viability.
Ghesani M; Depuey EG; Rozanski A
Echocardiography; 2005 Feb; 22(2):165-77. PubMed ID: 15693785
[TBL] [Abstract][Full Text] [Related]
17. F-18 fluoro deoxyglucose SPECT for assessment of myocardial viability.
Fitzgerald J; Parker JA; Danias PG
J Nucl Cardiol; 2000; 7(4):382-7. PubMed ID: 10958281
[TBL] [Abstract][Full Text] [Related]
18. Comparison of 18FDG PET with thallium SPECT in the assessment of myocardial viability. A segmental model analysis.
Alexánderson E; Ricalde A; Romero-Ibarra JL; Meave A
Arch Cardiol Mex; 2006; 76(1):9-15. PubMed ID: 16749497
[TBL] [Abstract][Full Text] [Related]
19. Comparison of myocardial uptake of fluorine-18-fluorodeoxyglucose imaged with PET and SPECT in dyssynergic myocardium.
Bax JJ; Visser FC; Blanksma PK; Veening MA; Tan ES; Willemsen TM; van Lingen A; Teule GJ; Vaalburg W; Lie KI; Visser CA
J Nucl Med; 1996 Oct; 37(10):1631-6. PubMed ID: 8862297
[TBL] [Abstract][Full Text] [Related]
20. Assessment of myocardial viability by positron emission tomography.
Segall G
Nucl Med Commun; 2002 Apr; 23(4):323-30. PubMed ID: 11930185
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]